Evidence map›Paper›PMID 28794944›Full record

ArticleChemistryOpen2017

Potent Prearranged Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor.

Ben J Jones, Rosario Scopelliti, Alejandra Tomas, Stephen R Bloom, David J Hodson, Johannes Broichhagen

Open access · goldAbstract read
In one paragraph

Article in ChemistryOpen, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 40 citations in OpenAlex.

  1. Prolonged signaling of backbone-modified glucagon-like peptide-Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Ben J JonesImperial College London, Section of Investigative Medicine Division of Diabetes, Endocrinology and Metabolism London W12 0NN UK.ORCID 0000-0003-0461-2584
Rosario ScopellitiÉcole Polytechnique Fédérale de Lausanne ISIC SB, Laboratory of Protein Engineering Av. Forel 21015 Lausanne Switzerland.ORCID 0000-0001-8161-8715
Alejandra TomasImperial College London Section of Cell Biology and Functional Genomics, Department of Medicine London W12 0NN UK.ORCID 0000-0002-2290-8453
Stephen R BloomImperial College London, Section of Investigative Medicine Division of Diabetes, Endocrinology and Metabolism London W12 0NN UK.ORCID 0000-0003-1542-2348
David J HodsonInstitute of Metabolism and Systems Research (IMSR) and Centre of Membrane Proteins and Receptors (COMPARE) University of Birmingham Birmingham B15 2TT UK.ORCID 0000-0002-8641-8568
Johannes BroichhagenÉcole Polytechnique Fédérale de Lausanne ISIC SB, Laboratory of Protein Engineering Av. Forel 21015 Lausanne Switzerland.ORCID 0000-0003-3084-6595
Imperial College London · GBDiabetes UK · GBÉcole Polytechnique Fédérale de Lausanne · CHGenomics (United Kingdom) · GBMax Planck Institute for Medical Research · DE

Funding

Medical Research Council MR/K023667/1Medical Research Council MR/M012646/1Medical Research Council MR/N00275X/1Wellcome Trust
6 · The paper itself

Abstract

Drugs that allosterically modulate G protein-coupled receptor (GPCR) activity display higher specificity and may improve disease treatment. However, the rational design of compounds that target the allosteric site is difficult, as conformations required for receptor activation are poorly understood. Guided by photopharmacology, a set of prearranged positive allosteric modulators (PAMs) with restricted degrees of freedom was designed and tested against the glucagon-like peptide-1 receptor (GLP-1R), a GPCR involved in glucose homeostasis. Compounds incorporating a

Indexed as

allosterismBETPglucagon-like peptide-1 receptorsglucagon-like peptidesG protein-coupled receptorsstilbene

Identifiers

PMID28794944
PMCPMC5542757
OpenAlexW2622399951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.